Los Angeles Capital Management LLC Pmv Pharmaceuticals, Inc. Transaction History

Los Angeles Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	SELL	$6.01 - $8.93 $106,364 - $158,043	-17,698 Reduced 28.3%	44,832 $275,000
Q2 2023 Aug 03, 2023	BUY	$3.94 - $6.27 $49,143 - $78,205	12,473 Added 24.92%	62,530 $391,000
Q1 2023 May 04, 2023	SELL	$4.77 - $9.16 $4,355 - $8,363	-913 Reduced 1.79%	50,057 $238,000
Q4 2022 Feb 06, 2023	BUY	$8.17 - $12.95 $156,700 - $248,381	19,180 Added 60.33%	50,970 $443,000
Q3 2022 Nov 02, 2022	BUY	$11.4 - $17.18 $3,648 - $5,497	320 Added 1.02%	31,790 $378,000
Q2 2022 Aug 05, 2022	BUY	$9.23 - $22.43 $110,944 - $269,608	12,020 Added 61.8%	31,470 $448,000
Q1 2022 May 06, 2022	BUY	$14.86 - $23.55 $102,534 - $162,495	6,900 Added 54.98%	19,450 $405,000
Q3 2021 Nov 08, 2021	BUY	$26.84 - $36.58 $336,842 - $459,079	12,550 New	12,550 $374,000

41.9M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $73.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.